Denosumab-induced bone changes in a child: a case report

Pediatr Radiol. 2024 Jun;54(7):1224-1226. doi: 10.1007/s00247-024-05895-8. Epub 2024 Apr 20.

Abstract

We present the case of a 9-year-old girl who developed striking bone changes following two years of denosumab therapy for giant cell lesions of the jaw.

Keywords: Child; Denosumab; Giant cell tumor; Osseous sclerosis; RANKL; Radiography.

Publication types

  • Case Reports

MeSH terms

  • Bone Density Conservation Agents* / adverse effects
  • Child
  • Denosumab* / adverse effects
  • Female
  • Humans

Substances

  • Denosumab
  • Bone Density Conservation Agents